PR Newswire Health·· 7 小时前AI 评分25
Kos Biotechnology Partners 战略投资 Golden Age Health，加速罕见病疗法全球可及
Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies
AI 导读
Kos Biotechnology Partners 通过首只基金 Kos BioVentures 对 Golden Age Health 进行战略投资，其管理合伙人 Alex Tzoukas 将加入后者董事会。
来源：PR Newswire Health · prnewswire.com